Podcast
#23: Laboratory Investigations for Maternal Health Testing
Duration: 15 Minutes
Apr 20, 2022
Maternal health refers to the health of the women during pregnancy, childbirth, and the postnatal period. Each stage should be a positive experience, ensuring women and their babies reach their full potential for health and well-being. Prenatal care includes screening and diagnostic tests and they can provide valuable information about the baby's health. Understand the risks and benefits.
The obstetrician in partnership with the laboratory has tools that can contribute to maternal health, such as:
- Prenatal screening tests can identify potential genetic disorders and diagnostic tests, and,
- A diagnostic test is the only way to be sure of a diagnosis.
Learn in this episode what are the strategies to minimize the risk of alloimmunization in the maternal population and what are the recommendations for antenatal and post-delivery care testing.
This educational podcast activity is brought to you by Ortho Clinical Diagnostics, Inc., and is not certified for continuing medical education. Ortho Clinical Diagnostics, Inc. sponsors the program, and the speaker must present information following applicable FDA requirements.
About Our Speaker:
About Our Speaker:
Professor Robert Flower, PhD FFSc (RCPA) FASM
National Research Program Leader
Brisbane, Australia
Professor Robert Flower is a national leader in R&D at the Australian Red Cross Lifeblood. He has been teaching and supervising hospital and university blood banks for over 30 years. He has published over 400 publications with over 4000 citations and has helped over 50 students complete post-graduate research. In 2018, Dr. Flower was granted the Vice Chancellor’s Award for Excellence at Queensland University of Technology. The following year, he was awarded the Peter Schiff Award from the Australia and New Zealand Society for Blood Transfusion. Dr. Flower’s current interest include translating genetics to routine investigations, molecular modeling the structures defining blood groups, and evidence-based modeling of the risk of transfusion-transmission for various agents.
Professor Robert Flower is a national leader in R&D at the Australian Red Cross Lifeblood. He has been teaching and supervising hospital and university blood banks for over 30 years. He has published over 400 publications with over 4000 citations and has helped over 50 students complete post-graduate research. In 2018, Dr. Flower was granted the Vice Chancellor’s Award for Excellence at Queensland University of Technology. The following year, he was awarded the Peter Schiff Award from the Australia and New Zealand Society for Blood Transfusion. Dr. Flower’s current interest include translating genetics to routine investigations, molecular modeling the structures defining blood groups, and evidence-based modeling of the risk of transfusion-transmission for various agents.
